Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: The Mayo Clinic experience

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 5, 2012, Pages 728-734

  Alli, Oluseun O ^a   Singh, Inder M ^a   Holmes Jr , David R ^a   Pulido, Juan N ^b   Park, Soon J ^a   Rihal, Charanjit S ^a  

^a MAYO CLINIC   (United States)

^b DEPARTMENT OF UROLOGY   (United States)

Author keywords

cardiogenic shock; coronary artery bypass graft; left ventricular assist device; multivessel disease; percutaneous coronary interventions

Indexed keywords

CREATININE;

AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE;

AGED; CLINICAL COMPETENCE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; LEARNING CURVE; MALE; MINNESOTA; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84867897114     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23465     Document Type: Article

References (27)

1. Bounous EP, Mark DB, Pollock BG, Hlatky MA, Harrell FE Jr, Lee KL, Rankin JS, Wechsler AS, Pryor DB, Califf RM,. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 1988; 78 (Pt 2): I151-I157.
2. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M,. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983; 68: 785-795.
3. Nanas JN, Moulopoulos SD,. Counterpulsation: Historical background, technical improvements, hemodynamic and metabolic effects. Cardiology 1994; 84: 156-167.
4. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G,. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005; 26: 1276-1283.
5. Perera D, Stables R, Booth J, Thomas M, Redwood S,. The balloon pump-assisted coronary intervention study (BCIS-1): Rationale and design. Am Heart J 2009; 158: 910-916 e2.
6. Santa-Cruz RA, Cohen MG, Ohman EM,. Aortic counterpulsation: A review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv 2006; 67: 68-77.
7. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, Godfrey E, White HD, Lim J, LeJemtel T,. Cardiogenic shock complicating acute myocardial infarction-Etiologies, management and outcome: A report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000; 36 (Suppl A): 1063-1070.
8. Aragon J, Lee MS, Kar S, Makkar RR,. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention. Catheter Cardiovasc Interv 2005; 65: 346-352.
9. Thiele H, Smalling RW, Schuler GC,. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2007; 28: 2057-2063.
10. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G,. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001; 104: 2917-2922.
11. Magovern JA, Sussman MJ, Goldstein AH, Szydlowski GW, Savage EB, Westaby S,. Clinical results with the AB-180 left ventricular assist device. Ann Thorac Surg 2001; 71 (Suppl): S121-S124; discussion S144-S146.
12. Chaikof EL, Blankensteijn JD, Harris PL, White GH, Zarins CK, Bernhard VM, Matsumura JS, May J, Veith FJ, Fillinger MF, et al. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg 2002; 35: 1048-1060.
13. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, et al. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-227.
14. Califf RM, Phillips HR III, Hindman MC, Mark DB, Lee KL, Behar VS, Johnson RA, Pryor DB, Rosati RA, Wagner GS, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985; 5: 1055-1063.
15. Gimelli G, Wolff MR,. Hemodynamically supported percutaneous coronary revascularization improves left ventricular function in patients with ischemic dilated cardiomyopathy at very high risk for surgery: A single-center experience. J Invasive Cardiol 2008; 20: 642-646.
16. Vranckx P, Foley DP, de Feijter PJ, Vos J, Smits P, Serruys PW,. Clinical introduction of the TandemHeart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention. Int J Cardiovasc Intervent 2003; 5: 35-39.
17. Giombolini C, Notaristefano S, Santucci S, Fortunati F, Savino K, Sindaco FD, Ragni T, Allegri M, Ambrosio G,. Percutaneous left ventricular assist device, TandemHeart, for high-risk percutaneous coronary revascularization. A single centre experience. Acute Card Care 2006; 8: 35-40.
18. Al-Husami W, Yturralde F, Mohanty G, Pastore C, Lotun K, Venesy D, Waxman S, Pyne C, Gossman D, Nesto R, et al. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol 2008; 20: 319-322.
19. Rajdev S, Irani A, Sharma S, Kini A,. Clinical utility of TandemHeart for high-risk tandem procedures: Percutaneous balloon aortic valvuloplasty followed by complex PCI. J Invasive Cardiol 2007; 19: E346-E349.
20. Rajdev S, Krishnan P, Irani A, Kim MC, Moreno PR, Sharma SK, Kini AS,. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: Single-center experience. J Invasive Cardiol 2008; 20: 67-72.
21. Thomas JL, Al-Ameri H, Economides C, Shareghi S, Abad DG, Mayeda G, Burstein S, Shavelle DM,. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock. J Invasive Cardiol 2010; 22: 360-364.
22. Vranckx P, Meliga E, De Jaegere PP, Van den Ent M, Regar ES, Serruys PW,. The TandemHeart, percutaneous transseptal left ventricular assist device: A safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience. EuroIntervention 2008; 4: 331-337.
23. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW,. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152: 469.e1-469.e8.
24. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S,. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: A randomized controlled trial. JAMA 2010; 304: 867-874.
25. O'Neill W,. Prospective Multicenter Trial Comparing Impella 2.5 to IABP in high risk PCI. Presented at the American College of Cardiology Meeting, New Orleans 2010.
26. Lemos PA, Cummins P, Lee CH, Degertekin M, Gardien M, Ottervanger JP, Vranckx P, de Feyter P, Serruys PW,. Usefulness of percutaneous left ventricular assistance to support high-risk percutaneous coronary interventions. Am J Cardiol 2003; 91: 479-481.
27. Burkhoff D, O'Neill W, Brunckhorst C, Letts D, Lasorda D, Cohen HA,. Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock. Catheter Cardiovasc Interv 2006; 68: 211-217.